References
- Stoltz, R. A., Conners, M. S., Gerritsen, M. E., Abraham, N. G. and Laniado-Schwartzman, M. (1996) Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid. Am. J. Pathol. 148, 129-139
- Cursiefen, C., Cao, J., Chen, L., Liu, Y., Maruyama, K. Jackson, D., Kruse, F. E., Wiegand, S. J., Dana, M. R. and Streilein, J. W. (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal ransplantation by neutralizing VEGF promotes graft survival. Invest. Ophthalmol. Vis. Sci. 45, 2666-2673 https://doi.org/10.1167/iovs.03-1380
- Casey, R. and Li, W. W. (1997) Factors controlling ocular angiogenesis. Am. J. Ophthalmol. 124, 521-529 https://doi.org/10.1016/S0002-9394(14)70868-2
- Chang, J. H., Gabison, E. E., Kato, T. and Azar, D. T. (2001) Corneal neovascularization. Curr. Opin. Ophthalmol. 12, 242-249 https://doi.org/10.1097/00055735-200108000-00002
- Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H., Benedict, W. and Bouck, N. P. (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285, 245-248 https://doi.org/10.1126/science.285.5425.245
- Zhang, P., Wu, D., Ge, J., Zhu, Z., Feng, G., Yue, T., Lin, J. and Zheng, H. (2003) Experimental inhibition of corneal neovascularization by endostatin gene transfection in vivo. Chin. Med. J. (Engl.) 116, 1869-1874
- Ormerod, L. D., Abelson, M. B. and Kenyon, K. R. (1989) Standard models of corneal injury using alkali-immersed filter discs. Invest. Ophthalmol. Vis. Sci. 30, 2148-2153
- Ormerod, L. D., Garsd, A., Reddy, C. V., Gomes, S. A., Abelson, M. B. and Kenyon, K. R. (1989) Dynamics of corneal epithelial healing after an alkali burn. A statistical analysis. Invest. Ophthalmol. Vis. Sci. 30, 1784-1793
- Chung, J. H. and Fagerholm, P. (1989) Corneal alkali wound healing in the monkey. Acta. Ophthalmol. (Copenh.) 67, 685-693 https://doi.org/10.1111/j.1755-3768.1989.tb04402.x
- Ferrara, N., Hillan, K. J. and Novotny, W. (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem. Biophys. Res. Commun. 333, 328-335 https://doi.org/10.1016/j.bbrc.2005.05.132
- Rosenfeld, P. J., Fung, A. E. and Puliafito, C. A. (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic. Surg. Lasers Imaging 36, 336-339
- Kao, W. W., Ebert, J., Kao, C. W., Covington, H. and Cintron, C. (1986) Development of monoclonal antibodies recognizing collagenase from rabbit PMN; the presence of this enzyme in ulcerating corneas. Curr. Eye Res. 5, 801-815 https://doi.org/10.3109/02713688609029231
- Burns, F. R., Gray, R. D. and Paterson, C. A. (1990) Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide. Invest. Ophthalmol. Vis. Sci. 31,107-114
- Manzano, R. P., Peyman, G. A, Khan, P., Carvounis, P. E., Kivilcim, M., Ren, M., Lake, J. C. and Chevez-Barrios, P. (2007) Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin). Br. J. Ophthalmol. 91, 804-807 https://doi.org/10.1136/bjo.2006.107912
- Moromizato, Y., Stechschulte, S., Miyamoto, K., Murata, T., Tsujikawa, A., Joussen, A. M. and Adamis, A. P. (2000) CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am. J. Pathol. 157, 1277-1281 https://doi.org/10.1016/S0002-9440(10)64643-3
- Hosseini, H. and Nejabat, M. (2007) A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents. Med. Hypotheses 68, 799-801 https://doi.org/10.1016/j.mehy.2006.06.063
- Lee, J. Y. and Lee, K. J. (2008) Histological changes on the wound healing process of alkali burned mouse cornea. J. Korean Oph. Opt. Soc. 13, 161-169
- Desmouliere, A., Darby, I. A. and Gabbiani, G. (2003) Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Invest. 83, 1689-1707 https://doi.org/10.1097/01.LAB.0000101911.53973.90
- Jester, J. V., Huang, J., Petroll, W. M. and Cavanagh, H. D. (2002) TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. Exp. Eye Res. 75, 645-657 https://doi.org/10.1006/exer.2002.2066
- Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. and Brown, R. A. (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349-363 https://doi.org/10.1038/nrm809
- Piek, E., Ju, W. J., Heyer, J., Escalante-Alcalde, D., Stewart, C. L., Weinstein, M., Deng, C., Kucherlapati, R., Bottinger, E. P. and Roberts, A. B. (2001) Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem. 276, 19945-19953 https://doi.org/10.1074/jbc.M102382200
- Evans, R. A., Tian, Y. C., Steadman, R. and Phillips, A. O. (2003) TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp. Cell Res. 282, 90-100 https://doi.org/10.1016/S0014-4827(02)00015-0
- Wilson, S. E., Mohan, R. R., Ambrosio, R., Hong, J. and Lee, J. (2001) The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog. Retin. Eye Res. 20, 625-637 https://doi.org/10.1016/S1350-9462(01)00008-8
- Stramer, B. M., Zieske, J. D., Jung, J. C., Austin, J. S. and Fini, M. E. (2003) Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest. Ophthalmol. Vis. Sci. 44, 4237-4246 https://doi.org/10.1167/iovs.02-1188
- Bascom, C. C., Wolfshohl, J. R., Coffey, R. J., Madisen, L., Webb, N. R., Purchio, A. R., Derynck, R. and Moses, H. L. (1989) Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol. Cell Biol. 9, 5508-5515 https://doi.org/10.1128/MCB.9.12.5508
- Dwivedi, D. J., Pontoriero, G. F., Ashery-Padan, R., Sullivan, S., Williams, T. and West-Mays, J. A. (2005) Targeted deletion of AP-2alpha leads to disruption in corneal epithelial cell integrity and defects in the corneal stroma. Invest. Ophthalmol. Vis. Sci. 46, 3623-3630 https://doi.org/10.1167/iovs.05-0028
- Yoeruek, E., Ziemssen, F., Henke-Fahle, S., Tatar, O., Tura, A., Grisanti, S., Bartz-Schmidt, K. U. and Szurman, P. (2008) Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal eovascularization after chemical burn. Acta. Ophthalmol. 86, 322-328 https://doi.org/10.1111/j.1600-0420.2007.01049.x
Cited by
- Prevention of arthrofibrosis by monoclonal antibody against vascular endothelial growth factor: A novel use of bevacizumab in rabbits vol.98, pp.7, 2012, https://doi.org/10.1016/j.otsr.2012.05.020
- Neovascular growth in an experimental alkali corneal burn model vol.89, pp.8, 2014, https://doi.org/10.1016/j.oftale.2014.08.012
- Concentration change of TGF -β 1 in aqueous humor of rabbits vol.7, pp.3, 2014, https://doi.org/10.1016/S1995-7645(14)60029-8
- Inhibition of Rho-Associated Kinase Prevents Pathological Wound Healing and Neovascularization After Corneal Trauma vol.34, pp.9, 2015, https://doi.org/10.1097/ICO.0000000000000493
- Corneal Neovascularization: An Anti-VEGF Therapy Review vol.57, pp.5, 2012, https://doi.org/10.1016/j.survophthal.2012.01.007
- Comprehensive Modeling of Corneal Alkali Injury in the Rat Eye 2017, https://doi.org/10.1080/02713683.2017.1317817
- Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells vol.32, pp.10, 2016, https://doi.org/10.1089/jop.2016.0094
- Bevacizumab and Ocular Wound Healing After Primary Pterygium Excision vol.27, pp.1, 2011, https://doi.org/10.1089/jop.2010.0094
- Bevacizumab eye drops delay corneal epithelial wound healing and increase the stromal response to epithelial injury in rats 2013, https://doi.org/10.1111/ceo.12085
- Crecimiento neovascular en un modelo experimental de quemadura corneal por álcali vol.89, pp.8, 2014, https://doi.org/10.1016/j.oftal.2014.02.016
- Intraperitoneal Administration of Bevacizumab Intraoperatively Does Not Affect Abdominal Wound Healing in Rats vol.47, pp.1, 2011, https://doi.org/10.1159/000327970
- Bevacizumab Revisited: Its Use in Different Mouse Models of Ocular Pathologies vol.40, pp.6, 2015, https://doi.org/10.3109/02713683.2014.943910
- Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery vol.93, pp.7, 2015, https://doi.org/10.1111/aos.12766
- Progress in corneal wound healing vol.49, 2015, https://doi.org/10.1016/j.preteyeres.2015.07.002